Saha, D., Wakimoto, H., Peters, C., Antoszczyk, S. J., Rabkin, S. D., & Martuza, R. L. (2018). Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models. Clin Cancer Res.
Citación estilo ChicagoSaha, Dipongkor, Hiroaki Wakimoto, Cole Peters, Slawomir J. Antoszczyk, Samuel D. Rabkin, y Robert L. Martuza. "Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-like Cell Models." Clin Cancer Res 2018.
Cita MLASaha, Dipongkor, et al. "Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-like Cell Models." Clin Cancer Res 2018.
Precaución: Estas citas no son 100% exactas.